Regeneron Pharmaceuticals Inc. buy Joe130978
Start price
07.04.23
/
50%
€760.00
Target price
07.04.24
-
Performance (%)
13.42%
End price
07.04.24
€862.00
Summary
This prediction ended on 07.04.24 with a price of €862.00. The BUY prediction by Joe130978 finished with a performance of 13.42%. Joe130978 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 7.756% | 7.756% | 22.311% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Joe130978 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Joe130978 hat das Wertpapier Regeneron Pharmaceuticals Inc. in seinem Wikifolio Die ganze Welt der Biotechs gekauft.
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Joe130978 gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Joe130978 for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€638.60
06.04.22
06.04.22
-
06.04.23
06.04.23
17.91%
06.04.23
06.04.23
